In addition, ROC curves of six prognosis-related DEGs indicated that CXCL1 and FABP4 had high accuracies in predicting survival in colon cancer patients (AUC >0.9; Figures 5(c) and 5(d)). Here, FABP4 is linked to malignant colon neoplasm.